TOI insiders were on both sides of the trade this year. Buys came to roughly $2.6 million (one buyer), sales to $863,000 (five sellers).
Chernett Jorey (10% Owner) made the biggest buy, worth around $768,000.
Zooming out by quarter: 3 quarters in a row of net buying by insiders. Insiders bought in 4 of the last 7 full quarters.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Jul 22, 2026 | Chernett Jorey | 10% Owner | Buy | 18,000 | $5.27 | $95K | SEC |
| Jul 16, 2026 | Podnos Yale | Executive Officer | Sell | 5,478 | $6.35 | $35K | SEC |
| Jul 16, 2026 | Podnos Yale | Executive Officer | Sell | 17,974 | $6.43 | $116K | SEC |
| Jul 13, 2026 | Chernett Jorey | 10% Owner | Buy | 15,000 | $5.85 | $88K | SEC |
| Jun 24, 2026 | Chernett Jorey | 10% Owner | Buy | 18,000 | $5.02 | $90K | SEC |
| Jun 9, 2026 | Podnos Yale | Executive Officer | Sell | 23,451 | $5.38 | $126K | SEC |
| Jun 5, 2026 | Chernett Jorey | 10% Owner | Buy | 12,000 | $4.75 | $57K | SEC |
| May 21, 2026 | Chernett Jorey | 10% Owner | Buy | 33,500 | $4.07 | $136K | SEC |
| May 21, 2026 | Chernett Jorey | 10% Owner | Buy | 5,000 | $4.05 | $20K | SEC |
| May 20, 2026 | Chernett Jorey | 10% Owner | Buy | 30,000 | $4.09 | $123K | SEC |
| Apr 16, 2026 | Kaushal Mohit | Director | Sell | 38,433 | $3.50 | $135K | SEC |
| Apr 16, 2026 | Kaushal Mohit | Director | Sell | 57,286 | $3.50 | $201K | SEC |
| Apr 13, 2026 | Chernett Jorey | 10% Owner | Buy | 20,000 | $3.10 | $62K | SEC |
| Mar 30, 2026 | Chernett Jorey | 10% Owner | Buy | 27,429 | $2.96 | $81K | SEC |
| Mar 27, 2026 | Chernett Jorey | 10% Owner | Buy | 50,000 | $3.15 | $158K | SEC |
In the last 12 months Oncology Institute, Inc. insiders made open-market purchases worth about $2.6 million and sales worth about $863,000. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
The most recent open-market insider trade in TOI was filed on 2026-07-22.
No congressional trades in TOI were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).